thrombosis
AML, acute myeloid leukemia; MDS, myelodysplastic syndrome.
Platelets circulate along the vessel wall and act to stop bleeding at sites of vessel injury. This hemostatic process requires multiple ligand-receptor interactions to tether, activate, and aggregate platelets. The tightly controlled platelet activation and aggregation that occurs at the site of vascular injury during hemostasis can become dysregulated in pathological conditions, promoting thrombosis and inflammation. For example, platelets promote arterial thrombosis or thromboembolism when activated either on the surface of a ruptured atherosclerotic plaque or by pathological levels of high fluid shear stress in the area of arterial stenosis, leading to acute thrombotic events such as ischemic stroke and myocardial infarction ( 11 ). Emerging evidence further suggests that platelets also act as a cellular mediator in a variety of pathophysiological conditions such as cancer, rheumatoid arthritis, atherosclerosis, trauma, and immune response ( 12 – 14 ). How transcription factors regulate platelet production from megakaryocytes has been extensively reported, but their non-transcriptional activities (i.e., activity independent of gene regulations) have only begun to be recognized. Here, we discuss several transcription factors that have been reported to regulate platelet production and function.
2.1. runt-related transcription factor 1.
In 1969, Weiss, et al. identified a family with an autosomal dominant inherited thrombocytopenia, caused primarily by decreased dense granule contents ( 15 ). A heterozygous Y260X mutation in the RUNX1 gene was subsequently shown to be the genetic basis of this inherited platelet defect ( 15 , 16 ). To date, more than 200 families with RUNX1 variants have been reported ( 17 ). RUNX1/AML1 (also known as CBFA2 and PEBP2αB) is a member of the Runt family, which has three known transcription factors (RUNX1, RUNX2, and RUNX3), which share the Runt homology domain near the N-terminus. This domain interacts with CBFb to bind specific sequences of DNA to regulate its transcription ( 18 ).
RUNX1 regulates several genes that control platelet production, structure, function, and intracellular signaling. One report found that 22 patients in a family with autosomal dominant thrombocytopenia had mutations in the RUNX1 gene ( 19 ) and 6 of them developed hematologic malignancies ( 20 ). RUNX1-deficient mice die in uterus due to defective hematopoiesis and resultant severe bleeding ( 21 , 22 ). Mice with the conditional knockout survive but have an impaired megakaryocyte maturation with a significant reduction in megakaryocyte polyploidization ( 23 ). Variations in the RUNX1 gene often result in bleeding diathesis, primarily because of defective platelet granules ( 15 , 16 ), which reduce platelet activation and aggregation ( 24 ). For example, mice carrying the RUNX1 p.Leu43Ser variant (equivalent to human p.Leu56Ser) exhibit a prolonged bleeding time because of defective α-granule secretion and platelet spreading ( 25 ). RUNX1 deficiency can result in pallidin dysregulation and deficient dense granules in platelets ( 26 ) as well as the Ras-related protein RAB31-mediated early endosomal trafficking of von Willebrand factor (VWF) and epidermal growth factor receptor (EGFR) in megakaryocytes ( 27 ). RUNX1 regulates the development of platelet granules through interaction with genes involved in the biogenesis of platelet granules such as the nuclear factor erythroid 2 (NF-E2).
In addition, RUNX1 can also regulate genes related to platelet functions. For example, it regulates the transcription of the non-muscle myosin IIA (MYH9) and IIB (MYH10) genes, which encode non-muscle myosin II heavy chains; RUNX1 mutations are associated with dysregulated expression of MYH10 in platelets ( 28 ); and the expression level of non-muscle myosin is used as a marker for changes in transcriptional activity of RUNX1 as well as friend leukemia integration 1 transcription factor (FLI1) ( 29 ). RUNX1 also regulates the expression of the arachidonate 12-lipoxygenase gene (ALOX12) ( 30 ), which encodes the enzyme that acts on polyunsaturated fatty acid substrates to generate bioactive lipid mediators to regulate platelet function ( 30 ). PCTP (phosphatidylcholine transfer protein) regulates the intermembrane transfer of phosphatidylcholine and its upregulation by RUNX1 sensitizes platelet response to thrombin through protease-activated receptor 4 ( 31 ). RUNX1 also regulates the expression of platelet factor 4 through coordination with transcription factors in the ETS family that share a conserved winged helix-turn-helix DNA binding domain that recognizes unique DNA sequences containing GGAA/T ( 32 ). Platelet factor 4 belongs to the CXC chemokine family and is released from α-granules of activated platelets to promote coagulation and to participate in heparin-induced thrombocytopenia ( 33 , 34 ). A recent report shows that RUNX-1 haploinsufficiency inhibits the differentiation of hematopoietic progenitor cells (HPCs) into megakaryocytes ( 35 ).
GATA-binding protein 1 (GATA1) is a transcription factor that contains two zinc finger domains: a C-terminal zinc finger that binds the (T/A) GATA(A/G) motif of DNA and an N-terminal zinc finger that is required for stabilizing the C-terminal structure and also interacts with a nuclear co-factor protein called friend for GATA1 (FOG1), which stabilizes GATA1 binding ( 36 , 37 ). GATA plays a pivotal role in hematopoietic development and is found in megakaryocytes ( 38 ). GATA1-deficient mice die before birth at approximately embryonic day 10, primarily because of severe anemia ( 39 ). However, mutations in the N-terminal zinc finger domain, which reduces the transcriptional activation of GATA1 ( 36 , 40 ), are found in patients with myeloproliferative disorders and acute megakaryoblastic leukemia ( 41 ), suggesting that GATA1-FOG1 interaction is essential for the development and maturation of megakaryocytes, the parental cells of platelets. Decreased GATA-1 expression has also been reported in patients with myelodysplastic syndrome ( 42 ).
Embryonic stem cells from GATA1-deficient mice are smaller and show low expression of megakaryocytic markers, but have a high rate of proliferation ( 43 ). Complementation of these cells with a wild-type GATA1 gene allows megakaryocytes and erythrocytes to develop in response to a variety of cytokines. Additionally, cell division is attenuated in the megakaryocytic progenitor G1ME cells that overexpress GATA1. A recent report further shows that impaired MYH10 silencing causes GATA1-related polyploidization defect during megakaryocyte differentiation ( 44 ).
Furthermore, platelet aggregation induced by collagen is inhibited in GATA1 - deficient mice ( 45 ), primarily due to reduced expression of the collagen receptor GPVI. Platelet adhesion and aggregation induced by shear stress are also reduced in GATA1 - deficient mice ( 45 ). How a GATA1 deficiency causes these changes in platelet reactivity remains unknown, but these phenotypic changes in the mice provide the first indication that transcription factors could perform non-transcriptional activities in anucleated platelets.
3.1. signal transducer and activator of transcription 3.
STAT includes a family of transcription factors critical for inflammatory and acute-phase reactions ( 46 , 47 ). They also play vital roles in cancer development and hematopoiesis ( 48 ). The homologous STAT1, STAT3, and STAT5 are expressed in human platelets and are reported to regulate platelet reactivity through residual or mitochondrial transcriptional activity in platelets. For example, STAT3 affects mitochondrial transcription by binding to the regulatory D-loop region of mitochondrial DNA upon platelet activation ( 49 ).
However, STAT3 can also be activated (phosphorylated) and dimerized in platelets stimulated with thrombopoietin ( 49 , 50 ), suggesting that STAT3 can also regulate platelet reactivity through non-transcriptional means. We have shown that STAT3 is activated and dimerized in collagen-stimulated platelets to serve as a protein scaffold that facilitates the catalytic interaction between spleen tyrosine kinase (Syk) and its substrate, PLCγ to enhance collagen-induced calcium mobilization and platelet activation ( 8 ). More importantly, STAT3 is activated to form dimers by a complex of IL-6 with its soluble receptor IL-6Rα, which activates JAK2 ( 51 ). The pharmacological inhibition of platelet STAT3 reduces collagen-induced platelet aggregation and thrombus formation on the collagen matrix ( 8 , 52 ). Platelets from STAT3-deficient mice or mice infused with a STAT3 inhibitor have reduced collagen-induced aggregation. This non-transcriptional activity of STAT3 may be critical for the development of platelet hyper-reactivity, which has been widely associated with inflammation, especially that related to the activity of the proinflammatory cytokine IL-6 ( 8 ). We have also shown that the piper longum derivative piperlongumine (PL) blocks collagen-induced platelet reactivity in a dose-dependent manner by targeting STAT3 ( 53 ). Consistent with our observations, the small molecular STAT3 inhibitor SC99 has been shown to reduce platelet activation and aggregation induced by collagen and thrombin ( 54 ). These findings offer a new pathway for reducing platelet hyper-reactivity in conditions of inflammation and in prothrombotic states associated with trauma, cancer, autoimmune diseases, and severe infection.
Nuclear factor kappa β (NFκB) is a well-defined redox-sensitive transcription factor that regulates the immune response and inflammation by controlling the expression of multiple genes activated by inflammatory mediators ( 55 – 57 ). Blocking NFκB can therefore improve outcomes of inflammatory diseases ( 58 ). NFκB is composed of p50 and p65 subunits, normally as an inactive cytoplasmic complex. The inhibitory proteins of the IκB family tightly bind the subunits of NFκB ( 59 ). Upon activation, the IκK complex phosphorylates IκBα, thus activating NFκB by detaching it from IkBα ( 60 – 62 ). Three IκK family members, α, β, and γ, are expressed in platelets, with β being the most abundant, and are reported to regulate platelet reactivity through non-transcriptional activity ( 9 , 10 , 63 ). For example, the pharmacological inhibition of IκKβ leads to reduced agonist-induced platelet activation, increased bleeding time, and prolonged thrombus formation in a mouse model ( 64 ). NF-κB has also been reported to be partially involved in the regulation of SERCA activity to regulate calcium homeostasis in platelets ( 65 ). IκKβ-deficient platelets lose the ability to shed the ectodomain of GP Ibα in response to ADP or collagen stimulations ( 66 ) but preserve thrombin-induced GP Ibα shedding ( 67 ). Collagen-induced p65 and IκKβ phosphorylation is blocked by inhibition of MAP kinase, but not by inhibition of ERK in platelets ( 68 ). The thrombin-induced GP Ibα shedding requires p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) as its upstream and downstream molecules ( 68 , 69 ).
The peroxisome proliferator-activated receptors (PPARs) are ligand-activated receptors in the nuclear hormone receptor family. They contain three subtypes (PPARα, PPARβ/δ, and PPARγ), which are essential in the regulation of cell differentiation, development, and metabolism ( 70 – 72 ). All PPARs heterodimerize with retinoid X receptor (RXR) and subsequently bind to a specific region of target genes called a peroxisome proliferator response element (PPRE) ( 73 ). PPARγ plays a transcription factor role in regulating platelet production from megakaryocytes, but the PPARγ ligand thiazolidinedione inhibits platelet aggregation induced by ADP under hydrostatic pressure and in diabetic mice ( 74 – 76 ). Similarly, activating PPARβ/δ also reduces platelet reactivity to ADP, thrombin, and collagen ( 77 , 78 ). However, PPARα is also required for platelet activation and thrombus formation, in which it regulates the dense granule secretion of platelets in hyperlipidemic mice ( 79 ). The reason for this apparent contradiction remains to be further investigated. PPARγ is recruited and phosphorylated by Syk to promote the recruitment of the protein called Linker for the Activation of T cells (LAT), which is necessary for collagen-induced platelet activation through glycoprotein VI ( 80 ).
While transcription factors are critically involved in megakaryocyte development and platelet production, they may also regulate platelet reactivity to conventional and specific platelet agonists ( Figure 1 ). The latter is independent of transcriptional activity, for which it is present but at a residual level. This non-transcriptional activity remains poorly understood and requires further investigation because it helps understanding how platelets are activated either by conventional agonists for hemostasis or as complications found in patients treated with drugs that block transcriptional activity of cells (e.g., cancer treatments). Such research will also play an important role in developing new therapeutics targeting these transcription factors to enhance or reduce platelet reactivity.
Transcription factors regulate platelet aggregation through non-transcriptional activities. (A) PPARγ is recruited and phosphorylated by Syk to promote the recruitment of LAT and enhance platelet aggregation; (B) NFκB is activated by upstream p38 mitogen-activated protein kinase (MAPK) and promotes platelet aggregation by regulating downstream extracellular signal-regulated kinase (ERK); (C) A complex of IL-6 with its soluble receptor IL-6R activates JAK2 to phosphorylate and dimerize STAT3, then the activated STAT3 serves as a protein scaffold to facilitate the catalytic interaction between the spleen tyrosine kinase (Syk) and its substrate PLCγ2 to promote platelet aggregation.
Extracellular vesicles (EVs) are shed membrane fragments, intracellular organelles, and nuclear components from cells undergoing active microvesiculation ( 81 – 84 ) or apoptosis ( 85 – 87 ). The former is triggered by the activation of the cysteine protease calpain, which disrupts the membrane-cytoskeleton association ( 88 – 91 ). Platelets are the primary source of EVs circulating in blood, accounting for approximately 80% of total EVs ( 92 – 94 ). The subcellular size of EVs allows them to travel to areas where parental cells are unable to go. In additional to inherent functions from their parental cells, EVs also perform unique activities of their own because of molecules expressed on their surface and carried by them, the latter of which include transcription factors such as STAT3, STAT5, and PPARγ ( 95 ) as well as regulators of transcription factors ( 96 , 97 ). This EV-derived transcriptional activity has been scarcely reported but hold greats potential for influencing biological activities of target cells. For example, PPARγ in platelet EVs is taken up by monocytic THP-1 cells, where it induces the expression of fatty acid-binding protein-4 (FABP4). Monocytes receiving PPARγ-containing platelet EVs produce less inflammatory mediators and become more adherent through increased fibronectin production ( 95 ). Although reports on platelet-derived transcription factors remain very limited, a large body of evidence in the literature shows that platelet-derived EVs, especially EV-carried microRNAs, can change transcriptional activities, thus regulating the function of target cells. Platelet EV-carried NLR family pyrin domain containing 3 (NLRP3) stimulates endothelial cells to undergo pyroptosis through the NLRP3/nuclear factor (NF)-κB pathway ( 98 ). EVs from platelets stimulated with bacteria provoke proinflammatory activity of monocytes through the TRAF6/NFκB pathway ( 99 ). MicroRNA-142-3p carried by platelet-derived EVs promotes the proliferation of endothelial cells ( 100 ), whereas microRNA-126-3p-carrying platelet EVs can be internalized by macrophages to dose-dependently downregulate expression of target mRNA ( 101 ). These observations mostly pertain to phenotypic characterization with less information regarding the underlying pathways involved. Systemic studies of EV-carrying transcription factors and related mediators are therefore urgently needed.
Platelets lack a nucleus and de novo transcription, but a number of transcription factors are found in platelets and may have non-transcriptional activities that regulate platelet function. Transferring transcription factors between platelets and target cells through platelet EVs could also be a novel regulatory mechanism of cell-cell communications and a potential therapeutic target for a variety of pathologies.
HY and YL performed the literature search and compiled all the information from the researched articles and wrote the manuscript. ZZ, J-FD and JZ formulated, proposed, guided and wrote the manuscript. All authors contributed to the article and approved the submitted version.
This study is supported by Young Scientists Award 82022020 from the National Natural Science Foundation of China (ZZ), National Natural Science Foundation of China 81971176 (ZZ), 81271361, 81271359 (JZ), 81102447 (HY), National Natural Science Foundation of China State Key Program Grant 81330029, National Natural Science Foundation of China Major International Joint Research Project 81720108015 (JZ), and Postdoctoral Science Foundation of China Grants 2013M541190 (HY).
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Dei council and dei faculty committee, biology diversity community, mit biology catalyst symposium, honors and awards, employment opportunities, faculty and research, current faculty, in memoriam, areas of research, biochemistry, biophysics, and structural biology, cancer biology, cell biology, computational biology, human disease, microbiology, neurobiology, stem cell and developmental biology, core facilities, video gallery, faculty resources, undergraduate, why biology, undergraduate testimonials, major/minor requirements, general institute requirement, advanced standing exam, transfer credit, current students, subject offerings, research opportunities, biology undergraduate student association, career development, why mit biology, diversity in the graduate program, nih training grant, career outcomes, graduate testimonials, prospective students, application process, interdisciplinary and joint degree programs, living in cambridge, graduate manual: key program info, graduate teaching, career development resources, biology graduate student council, biopals program, postdoctoral, life as a postdoc, postdoc associations, postdoc testimonials, workshops for mit biology postdocs entering the academic job market, responsible conduct of research, postdoc resources, non-mit undergraduates, bernard s. and sophie g. gould mit summer research program in biology (bsg-msrp-bio), bsg-msrp-bio gould fellows, quantitative methods workshop, high school students and teachers, summer workshop for teachers, mit field trips, leah knox scholars program, additional resources, mitx biology, biogenesis podcast, biology newsletter, department calendar, ehs and facilities, graduate manual, resources for md/phd students, preliminary exam guidelines, thesis committee meetings, guidelines for graduating, mentoring students and early-career scientists, remembering stephen goldman (1962 – 2022), it takes three to tango: transcription factors bind dna, protein, and rna.
July 7, 2023.
Transcription factors could be the Swiss Army knives of gene regulation; they are versatile proteins containing multiple specialized regions. On one end they have a region that can bind to DNA. On the other end they have a region that can bind to proteins. Transcription factors help to regulate gene expression—turning genes on or off and dialing up or down their level of activity—often in partnership with the proteins that they bind. They anchor themselves and their partner proteins to DNA at binding sites in genetic regulatory sequences, bringing together the components that are needed to make gene expression happen.
Transcription factors are a well-known family of proteins, but new research from Whitehead Institute Member Richard Young and colleagues shows that the picture we have had of them is incomplete. In a paper published in Molecular Cell on July 3 , Young and postdocs Ozgur Oksuz and Jonathan Henninger reveal that along with DNA and protein, many transcription factors can also bind RNA. The researchers found that RNA binding keeps transcription factors near their DNA binding sites for longer, helping to fine tune gene expression. This rethinking of how transcription factors work may lead to a better understanding of gene regulation, and may provide new targets for RNA-based therapeutics.
“It’s as if, after carrying around a Swiss Army knife all your life for its blade and scissors, you suddenly realize that the odd, small piece in the back of the knife is a screwdriver,” Young says. “It’s been staring you in the face this whole time, and now that you finally see it, it becomes clear how many more uses there are for the knife than you had realized.”
A few papers, including one from Young’s lab, had previously identified individual transcription factors as being able to bind RNA, but researchers thought that this was a quirk of the specific transcription factors. Instead, Young, Oksuz, Henninger and collaborators have shown that RNA-binding is in fact a common feature present in at least half of transcription factors.
“We show that RNA binding by transcription factors is a general phenomenon,” Oksuz says. “Individual examples in the past were thought to be exceptions to the rule. Other studies dismissed signs of RNA binding in transcription factors as an artifact—an accident of the experiment rather than a real finding. The clues have been there all along, but I think earlier work was so focused on the DNA and protein interactions that they didn’t consider RNA.”
The reason that researchers had not recognized transcription factors’ RNA binding region as such is because it is not a typical RNA binding domain. Typical RNA binding domains form stable structures that researchers can detect or predict with current technologies. Transcription factors do not contain such structures, and so standard searches for RNA binding domains had not identified them in transcription factors.
Young, Oksuz and Henninger got their biggest clue that researchers might be overlooking something from the human immunodeficiency virus (HIV), which produces a transcription factor-like protein called Tat. Tat increases the transcription of HIV’s RNA genome by binding to the virus’ RNA and then recruiting cellular machinery to it. However, Tat does not contain a structured RNA binding site; instead, it binds RNA from a region called an arginine-rich motif (ARM) that is unstructured but has a high affinity for RNA. When the ARM binds to HIV RNA, the two molecules form a more stable structure together.
The researchers wondered if Tat might be more similar to human transcription factors than anyone had realized. They went through the list of transcription factors, and instead of looking for structured RNA binding domains, they looked for ARMs. They found them in abundance; the majority of human transcription factors contain an ARM-like region between their DNA and protein binding regions, and these sequences were conserved across animal species. Further testing confirmed that many transcription factors do in fact use their ARMs to bind RNA.
Next, the researchers tested to see if RNA binding affected the transcription factors’ function. When transcription factors had their ARMs mutated so they couldn’t bind RNA, those transcription factors were less effective in finding their target sites, remaining at those sites and regulating genes. The mutations did not prevent transcription factors from functioning altogether, suggesting that RNA binding contributes to fine-tuning of gene regulation.
Further experiments confirmed the importance of RNA binding to transcription factor function. The researchers mutated the ARM of a transcription factor important to embryonic development, and found that this led to developmental defects in zebrafish. Additionally, they looked through a list of genetic mutations known to contribute to cancer and heritable diseases, and found that a number of these occur in the RNA binding regions of transcription factors. All of these findings point to RNA binding playing an important role in transcription factors’ regulation of gene expression.
They may also provide therapeutic opportunities. The transcription factors studied by the researchers were found to bind RNA molecules that are produced in the regulatory regions of the genome where the transcription factors bind DNA. This set of transcription factors includes factors that can increase or decrease gene expression. “With evidence that RNAs can tune gene expression through their interaction with positive and negative transcription factors,” says Henninger, “we can envision using existing RNA-based technologies to target RNA molecules, potentially increasing or decreasing expression of specific genes in disease settings.”
Ozgur Oksuz, Jonathan E. Henninger, Robert Warneford-Thomson, Ming M. Zheng, Hailey Erb, Adrienne Vancura, Kalon J. Overholt, Susana Wilson Hawken, Salman F. Banani, Richard Lauman, Lauren N. Reich, Anne L. Robertson, Nancy M. Hannett, Tong I. Lee, Leonard I. Zon, Roberto Bonasio, Richard A. Young. “Transcription factors interact with RNA to regulate genes.” Molecular Cell , July 3, 2023. https://doi.org/10.1016/j.molcel.2023.06.012 .
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Email citation, add to collections.
Your saved search, create a file for external citation management software, your rss feed.
Affiliations.
Tanshinones and phenolic acids are two important metabolites synthesized by the traditional Chinese medicinal plant Salvia miltiorrhiza. There is increasing market demand for these compounds. Here, we isolated and functionally characterized SmERF1L1, a novel JA (Jasmonic acid)-responsive gene encoding AP2/ERF transcription factor, from Salvia miltiorrhiza. SmERF1L1 was responsive to methyl jasmonate (MJ), yeast extraction (YE), salicylic acid (SA) and ethylene treatments. Subcellular localization assay indicated that SmERF1L1 located in the nucleus. Overexpression of SmERF1L1 significantly increased tanshinones production in transgenic S. miltiorrhiza hairy roots by comprehensively upregulating tanshinone biosynthetic pathway genes, especially SmDXR. Yeast one-hybrid (Y1H) and electrophoretic mobility shift assay (EMSA) showed that SmERF1L1 binds to the GCC-box of SmDXR promoter while dual luciferase (Dual-LUC) assay showed that SmERF1L1 positively regulated the expression of SmDXR. Our study suggested that the SmERF1L1 may be a good potential target for further metabolic engineering of bioactive component biosynthesis in S. miltiorrhiza.
Keywords: AP2/ERF transcription factor; Biosynthesis; Caffeic acid (PubChem CID: 689043); Cryptotanshinone (PubChem CID: 160254); Dihydrotanshinone (PubChem CID: 11425923); Phenolic acids; Rosmarinic acid (PubChem CID: 5315615); Salvia miltiorrhiza; Salvianolic acid A (PubChem CID: 5281793); Salvianolic acid B (PubChem CID: 11629084); Tanshinone I (PubChem CID: 114917); Tanshinone IIA (PubChem CID: 164676); Tanshinones.
Copyright © 2018 Elsevier Ltd. All rights reserved.
PubMed Disclaimer
Full text sources.
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
An integrative temperature-controlled microfluidic system for budding yeast heat shock response analysis at the single-cell level †.
* Corresponding authors
a The State Key Laboratory for Artificial Microstructures and Mesoscopic Physics, School of Physics, Peking University, Beijing, China E-mail: [email protected]
b Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
c Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China
Cells can respond and adapt to complex forms of environmental change. Budding yeast is widely used as a model system for these stress response studies. In these studies, the precise control of the environment with high temporal resolution is most important. However, there is a lack of single-cell research platforms that enable precise control of the temperature and form of cell growth. This has hindered our understanding of cellular coping strategies in the face of diverse forms of temperature change. Here, we developed a novel temperature-controlled microfluidic platform that integrates a microheater (using liquid metal) and a thermocouple (liquid metal vs. conductive PDMS) on a chip. Three forms of temperature changes (step, gradient, and periodical oscillations) were realized by automated equipment. The platform has the advantages of low cost and a simple fabrication process. Moreover, we investigated the nuclear entry and exit behaviors of the transcription factor Msn2 in yeast in response to heat stress (37 °C) with different heating modes. The feasibility of this temperature-controlled platform for studying the protein dynamic behavior of yeast cells was demonstrated.
Download citation, permissions.
J. Hong, H. He, Y. Xu, S. Wang and C. Luo, Lab Chip , 2024, Advance Article , DOI: 10.1039/D4LC00313F
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page .
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page .
Read more about how to correctly acknowledge RSC content .
Search articles by author.
This article has not yet been cited.
Juan Wang, Haiqin Zhang, Yuanjiang Wang, Shanshan Meng, Qing Liu, Qian Li, Zhiwen Zhao, Qiaoquan Liu, Cunxu Wei, Regulatory loops between rice transcription factors OsNAC25 and OsNAC20/26 balance starch synthesis, Plant Physiology , Volume 195, Issue 2, June 2024, Pages 1365–1381, https://doi.org/10.1093/plphys/kiae139
Several starch synthesis regulators have been identified, but these regulators are situated in the terminus of the regulatory network. Their upstream regulators and the complex regulatory network formed between these regulators remain largely unknown. A previous study demonstrated that NAM, ATAF, and CUC (NAC) transcription factors, OsNAC20 and OsNAC26 (OsNAC20/26), redundantly and positively regulate the accumulation of storage material in rice ( Oryza sativa ) endosperm. In this study, we detected OsNAC25 as an upstream regulator and interacting protein of OsNAC20/26. Both OsNAC25 mutation and OE resulted in a chalky seed phenotype, decreased starch content, and reduced expression of starch synthesis–related genes, but the mechanisms were different. In the osnac25 mutant, decreased expression of OsNAC20 / 26 resulted in reduced starch synthesis; however, in OsNAC25 -overexpressing plants, the OsNAC25–OsNAC20/26 complex inhibited OsNAC20/26 binding to the promoter of starch synthesis–related genes. In addition, OsNAC20/26 positively regulated OsNAC25 . Therefore, the mutual regulation between OsNAC25 and OsNAC20/26 forms a positive regulatory loop to stimulate the expression of starch synthesis–related genes and meet the great demand for starch accumulation in the grain filling stage. Simultaneously, a negative regulatory loop forms among the 3 proteins to avoid the excessive expression of starch synthesis–related genes. Collectively, our findings demonstrate that both promotion and inhibition mechanisms between OsNAC25 and OsNAC20/26 are essential for maintaining stable expression of starch synthesis–related genes and normal starch accumulation.
Personal account.
Sign in with a library card.
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society member access to a journal is achieved in one of the following ways:
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Click the account icon in the top right to:
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
Month: | Total Views: |
---|---|
March 2024 | 338 |
April 2024 | 259 |
May 2024 | 126 |
June 2024 | 123 |
Citing articles via.
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
Sign In or Create an Account
This PDF is available to Subscribers Only
For full access to this pdf, sign in to an existing account, or purchase an annual subscription.
IMAGES
VIDEO
COMMENTS
1. Introduction. Transcription is a crucial component of the central dogma of molecular biology (DNA-RNA-protein) [], serving as a bridge that translates genetic information into diverse forms at the individual level.Transcription factors (TFs) play a pivotal role in regulating the transcription of target genes by selectively recognizing and binding specific DNA regions known as TF binding ...
PREDICTING TRANSCRIPTION FACTOR BINDING USING NEURAL STRUCTURED LEARNING A Thesis in Bioinformatics and Genomics by Natalie Zesati Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science December 2020. ii The thesis of Natalie Zesati was reviewed and approved by the following: Shaun Mahony Assistant Professor of ...
Transcription factors are proteins that initiate and modulate transcription rate by interacting with specific DNA recognition sequences in the target genes. As shown in Fig. 1, these DNA-binding transcription factors are structurally classified into four major classes: Helix-turn-helix homeodomain (e.g. PBX1 ), C. 2. H. 2 . zinc
Hinojosa, Leetoria, Investigating the Localization of FOXO Transcription Factors in. Glioblastoma. Master of Sciences (MS), May, 2020, 32pp., 1 table, 7 figures, 17 references. The Phosphatidylinositol 3 Kinase (PI3K) pathway is an essential intracellular signaling. pathway that regulates cellular growth, survival, and fate.
The Human Transcription Factors. Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome. Despite keen interest in understanding how TFs control gene expression, it remains challenging to determine how the precise genomic binding sites of ...
Thesis proposal Functional Validation of Transcription Factor to Gene Interactions by Statistical Learning of Gaussian Bayesian networks from SNP and Expression data. Jing Xiang Machine Learning Department Carnegie Mellon University [email protected] Committee members: Seyoung Kim Geoff Gordon Carl Kingsford Steffi Oesterreich January 23, 2017
The overall objective of this thesis was to produce and characterize recombinant transducible (able to enter cells) transcription factors (TFs). TFs are complex, difficult-to-make proteins that regulate gene expression and cell fate. Thus, we wanted to deliver transducible TFs exogenously to cells to change gene expression and alter cell fate.
The transcription factors binding to a specific DNA region is a key in transcription regulation. Therefore, identifying transcription factor DBSs and verifying the interactions between transcription factors are key to understanding transcriptional regulatory mechanisms and networks (Fig. 2).Download : Download high-res image (438KB) Download : Download full-size image
The same concentration of GR as HTH transcription factor protein and BSA was prepared in 50 mM Tris and 150 mM NaCl at pH 7.0. The average of each dataset was used for the fitting process. Based ...
Transcription factors (TFs) drive significant cellular changes in response to environmental cues and intercellular signaling. Neighboring cells influence TF activity and, consequently, cellular fate and function. Spatial transcriptomics (ST) captures mRNA expression patterns across tissue samples, enabling characterization of the local microenvironment. However, these datasets have not been ...
This thesis explores the role of transcription factors in sensory neuron specification. We describe the transcription factor Foxs1 as an early sensory neuronal marker and use it to
Abstract. Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome. Despite keen interest in understanding how TFs control gene expression, it remains challenging to determine how the precise genomic binding sites of TFs are specified and ...
transcription factors to bind to DNA and slide until they find their consensus sequence. One transcription factor, AmrZ, functions as both an activator and repressor and studying ... thesis. The changes in conformation can also be due to the specific conformation of DNA. There are three main forms that DNA can take: A-, B-, and Z-form DNA ...
in the thesis, they were very helpful to the overall understanding of the role and function of bHLH transcription factors in various developmental lineages. Dr. Fancis Collins has given me a superb opportunity to pursue a postdoctoral project in the genomics of type 2 diabetes, and showed a lot of
RNA-guided transcription factors arose repeatedly via the domestication of transposon-encoded tnpB genes, representing a parallel evolutionary path to CRISPR-Cas adaptive immunity.
I have also applied supervised learning methods for predicting transcription factor binding locations based on combinations of regulatory motifs. For each experiment in a compendium of ChIP-chip studies, I constructed a classifier to distinguish between regions bound by the given factor and regions bound by any other factor. For each
Investigating the role of transcription factor, Trl, during germline development in the Drosophila ovary by Lindsay L. Davenport July 2019 Director of Thesis: Elizabeth T. Ables, Ph. D. Major Department: Biology Oogenesis is the process by which an egg develops from undifferentiated cells in the ovary.
A novel MADS-box transcription factor from Pinus radiata D. Don was characterized. PrMADS11 encodes a protein of 165 amino acids for a MADS-box transcription factor belonging to group II, related to the MIKC protein structure. PrMADS11 was differentially expressed in the stems of pine trees in response to 45° inclination at early times (1 h). Arabidopsis thaliana was stably transformed with a ...
The chemical synthesis of site-specifically modified transcription factors (TFs) is a powerful method to investigate how post-translational modifications (PTMs) influence TF-DNA interactions and impact gene expression. Among these TFs, Max plays a pivotal role in controlling the expression of 15 % of the genome. The activity of Max is regulated ...
These programs are fundamentally regulated at transcription and are orchestrated by sequence-specific transcription factors (TFs). The work presented here focuses on the wide-spread survey of TF activity, as well as an in depth study of a single TF, p53. ... The focus of the first part of this thesis is to define a computational model to assess ...
Background: Transcriptional factors (TFs) are responsible for regulating the transcription of pro-oncogenes and tumor suppressor genes in the process of tumor development. However, the role of these transcription factors in Bladder cancer (BCa) remains unclear. And the main purpose of this research is to explore the possibility of these TFs serving as biomarkers for BCa.
Illustration of an activator. In molecular biology, a transcription factor (TF) (or sequence-specific DNA-binding factor) is a protein that controls the rate of transcription of genetic information from DNA to messenger RNA, by binding to a specific DNA sequence. The function of TFs is to regulate—turn on and off—genes in order to make sure that they are expressed in the desired cells at ...
1. Introduction. Transcription factors (TFs) are a group of mediators that bind the promoter or regulatory sequence of a gene to control its rate of transcribing genetic information from DNA to messenger RNA ().This transcription control is key to ensuring an adequate level of expression of a given protein in targeted cells at a particular developmental stage.
Transcription factors could be the Swiss Army knives of gene regulation; they are versatile proteins containing multiple specialized regions. On one end they have a region that can bind to DNA. On the other end they have a region that can bind to proteins. Transcription factors help to regulate gene expression—turning genes on or off […]
Here, we isolated and functionally characterized SmERF1L1, a novel JA (Jasmonic acid)-responsive gene encoding AP2/ERF transcription factor, from Salvia miltiorrhiza. SmERF1L1 was responsive to methyl jasmonate (MJ), yeast extraction (YE), salicylic acid (SA) and ethylene treatments. Subcellular localization assay indicated that SmERF1L1 ...
Moreover, we investigated the nuclear entry and exit behaviors of the transcription factor Msn2 in yeast in response to heat stress (37 °C) with different heating modes. ... If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the ...
A previous study demonstrated that NAM, ATAF, and CUC (NAC) transcription factors, OsNAC20 and OsNAC26 (OsNAC20/26), redundantly and positively regulate the accumulation of storage material in rice (Oryza sativa) endosperm. In this study, we detected OsNAC25 as an upstream regulator and interacting protein of OsNAC20/26.
TRANSCRIPTION FACTOR BINDING SITES By LIANG ZHAO Bachelor of Science Zhejiang University Hangzhou, China 1992 . . Master of Engineering BetJmg Research Institute of Chemical Industry Beijing, China 1995 Submitted to the Faculty of the Graduate College of the Oklahoma State University in partial fulfillment of the requirements for the degree of